The frequent use of umbilical cord blood as the source of hematopoietic stem cells, both in children and adults who do not have related donors, has led to the establishment of a better standardization of selection criteria aiming at improving the results. The choice of the umbilical cord blood unit should be based on the total number of nucleated cells and the number of differences in the human leukocyte antigen (HLA) system. When a unit has minimal cellularity, the use of a double cord blood transplant should be considered. When two or more units have similar characteristics, the choice may be determined by the CD34 count, ABO compatibility and the quality and speed to obtain the unit.A frequente utilização de sangue de cordão umbilical - ...
Chronic myeloid leukemia (CML) is a rare event in childhood, comprising of less than 5% of all leuke...
Orientador: Sara Teresinha Olalla SaadDissertação (mestrado) - Universidade Estadual de Campinas, Fa...
Vinte e dois pacientes consecutivos portadores de leucemia mielóide aguda (LMA) em primeira remissão...
Umbilical Cord Blood is a rich source of hematopoietic stem cells widely used as a substitute of bon...
The Brazilian Bone Marrow Transplant Society (SBTMO) held its First Meeting on Bone Marrow Transplan...
The objective of this work was to define guidelines for the indication of hematopoietic stem cells t...
In spite of Anti-HLA antibodies being associated to rejection in solid organs transplantation, this ...
As células-tronco hematopoéticas (CTH) são células que possuem a capacidade de se autorrenovar e se ...
Portadores de leucemia linfoide crônica (LLC) apresentam curso clínico indolente e prolongado que de...
Atualmente, vários tipos de células-tronco hematopoéticas (CTH), provenientes de diferentes tecidos ...
Mobilized peripheral blood has replaced the use of bone marrow as a source of hematopoietic stem cel...
High-dose chemotherapy (HDT) followed by autologous bone marrow transplantation (ABMT) has proved to...
Na medicina, a importância das células-tronco hematopoéticas (CTH) é evidentepelo seu uso rotineiro ...
High dose chemotherapy followed by stem cell rescue is the treatment of choice for a variety of soli...
Data from the International Bone Marrow Transplant Registry (IBMTR) contribute for the improvement o...
Chronic myeloid leukemia (CML) is a rare event in childhood, comprising of less than 5% of all leuke...
Orientador: Sara Teresinha Olalla SaadDissertação (mestrado) - Universidade Estadual de Campinas, Fa...
Vinte e dois pacientes consecutivos portadores de leucemia mielóide aguda (LMA) em primeira remissão...
Umbilical Cord Blood is a rich source of hematopoietic stem cells widely used as a substitute of bon...
The Brazilian Bone Marrow Transplant Society (SBTMO) held its First Meeting on Bone Marrow Transplan...
The objective of this work was to define guidelines for the indication of hematopoietic stem cells t...
In spite of Anti-HLA antibodies being associated to rejection in solid organs transplantation, this ...
As células-tronco hematopoéticas (CTH) são células que possuem a capacidade de se autorrenovar e se ...
Portadores de leucemia linfoide crônica (LLC) apresentam curso clínico indolente e prolongado que de...
Atualmente, vários tipos de células-tronco hematopoéticas (CTH), provenientes de diferentes tecidos ...
Mobilized peripheral blood has replaced the use of bone marrow as a source of hematopoietic stem cel...
High-dose chemotherapy (HDT) followed by autologous bone marrow transplantation (ABMT) has proved to...
Na medicina, a importância das células-tronco hematopoéticas (CTH) é evidentepelo seu uso rotineiro ...
High dose chemotherapy followed by stem cell rescue is the treatment of choice for a variety of soli...
Data from the International Bone Marrow Transplant Registry (IBMTR) contribute for the improvement o...
Chronic myeloid leukemia (CML) is a rare event in childhood, comprising of less than 5% of all leuke...
Orientador: Sara Teresinha Olalla SaadDissertação (mestrado) - Universidade Estadual de Campinas, Fa...
Vinte e dois pacientes consecutivos portadores de leucemia mielóide aguda (LMA) em primeira remissão...